Profile: Isotechnika Inc. is a biopharmaceutical company that focuses on the discovery, development & delivery of immunosuppressive therapeutics for the treatment of autoimmune diseases and for use in the prevention of organ rejection in transplantation. Our TAFA93 is a prodrug of the mTOR inhibitor rapamycin which has completed phase 1 clinical development.
3 Products/Services (Click for related suppliers)
| |||||
• | Clinical Trials | • | Drug Development | • | Immunosuppressants |